Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$301,283
+$45,840 QoQ
Shares Held
832
+14.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#2,555
of 3,140 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quadcap Wealth Management, LLC holds $15,582,164 across 9 Drug Manufacturers - General names. AMGN ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,129 | $3,842,312 | |
| 2 | ABBV |
AbbVie Inc.
|
12,770 | $3,213,442 | |
| 3 | NVS |
Novartis AG
|
14,928 | $2,339,516 | |
| 4 | LLY |
ELI LILLY & Co
|
1,847 | $2,215,347 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,973 | $1,667,030 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,394 | $1,117,482 | |
| 7 | PFE |
Pfizer Inc
|
24,984 | $601,614 | |
| 8 | AMGN |
Amgen Inc
This page
|
832 | $301,283 |
All Filings in AMGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $301,283 | 832 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $255,443 | 726 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $247,773 | 757 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $242,692 | 860 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $245,984 | 881 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $267,621 | 859 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $216,331 | 830 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $274,522 | 852 | Shares | Sole | 2024-11-12 | |
| 2024-03-31 | $200,161 | 704 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $207,662 | 721 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||